191
Views
33
CrossRef citations to date
0
Altmetric
Article

Acute poisonings treated in hospitals in Oslo: A one-year prospective study (II): Clinical outcome

, M.D., , M.D., , Ph.D , M.D., , M.D., , M.D., , M.D., , Ph.D , M.D. & , Ph.D. , M.D. show all
Pages 42-49 | Received 16 Nov 2006, Accepted 10 Jan 2007, Published online: 29 Jun 2010
 

Abstract

Objectives. The changing pattern of acute poisoning may affect complications and outcome in these patients. An update study on acute poisonings was therefore performed and compared to similar data from 1980. Design. A prospective cross-sectional multi-center study of all adult patients (≥ 16 years) hospitalized in Oslo with a main diagnosis of acute poisoning, irrespective of intention, over a one-year period. Results. Of 947 admissions, 222 (23%) were comatose. Complications were observed in 173 (18%), slightly reduced from 1980 (22%). Ten (1.1%) died and six (0.6%) got permanent sequelae, of which seven and five were drug- or alcohol-related, respectively. Seventy-five percent received treatment besides observation; 39% received antidotes, increased from 21% in 1980, most frequently flumazenil (23%) and naloxone (14%). Conclusions. In-hospital mortality in poisoned patients remained low, few patients entailed complications, and most patients survived without permanent sequelae. Drug- and alcohol-abuse related poisonings were most severe.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.